These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6693863)

  • 1. The use of IgM tests for analysis of the causes of measles vaccine failures: experience gained in an epidemic in Hungary in 1980 and 1981.
    Nagy G; Kósa S; Takátsy S; Koller M
    J Med Virol; 1984; 13(1):93-103. PubMed ID: 6693863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of secondary vaccine failures in measles outbreaks.
    Mathias RG; Meekison WG; Arcand TA; Schechter MT
    Am J Public Health; 1989 Apr; 79(4):475-8. PubMed ID: 2929807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.
    Pannuti CS; Morello RJ; Moraes JC; Curti SP; Afonso AM; Camargo MC; Souza VA
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):119-22. PubMed ID: 14715557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection.
    Erdman DD; Heath JL; Watson JC; Markowitz LE; Bellini WJ
    J Med Virol; 1993 Sep; 41(1):44-8. PubMed ID: 8228936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of measles serodiagnosis during an outbreak in a vaccinated community.
    Sekla L; Stackiw W; Eibisch G; Johnson I
    Clin Invest Med; 1988 Aug; 11(4):304-9. PubMed ID: 3168353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.
    Paunio M; Hedman K; Davidkin I; Valle M; Heinonen OP; Leinikki P; Salmi A; Peltola H
    Epidemiol Infect; 2000 Apr; 124(2):263-71. PubMed ID: 10813152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population.
    Edmonson MB; Addiss DG; McPherson JT; Berg JL; Circo SR; Davis JP
    JAMA; 1990 May; 263(18):2467-71. PubMed ID: 2278542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological and clinical characteristics of measles vaccine failure in Japan.
    Hidaka Y; Aoki T; Akeda H; Miyazaki C; Ueda K
    Scand J Infect Dis; 1994; 26(6):725-30. PubMed ID: 7747097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary immune response in a vaccinated population during a large measles epidemic.
    Ozanne G; d'Halewyn MA
    J Clin Microbiol; 1992 Jul; 30(7):1778-82. PubMed ID: 1629334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles immunity in children vaccinated before one year of age.
    Schluederberg A; Lamm SH; Landrigan PJ; Black FL
    Am J Epidemiol; 1973 Jun; 97(6):402-9. PubMed ID: 4713935
    [No Abstract]   [Full Text] [Related]  

  • 13. Seroepidemiology and evaluation of passive surveillance during 1988-1989 measles outbreak in Taiwan.
    Lee MS; King CC; Jean JY; Kao CL; Wang CC; Ho MS; Chen CJ; Lee GC
    Int J Epidemiol; 1992 Dec; 21(6):1165-74. PubMed ID: 1483823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles outbreak in Ibadan: clinical, serological and virological identification of affected children in selected hospitals.
    Adu FD; Ikusika A; Omotade O
    J Infect; 1997 Nov; 35(3):241-5. PubMed ID: 9459395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.
    Waibale P; Bowlin SJ; Mortimer EA; Whalen C
    Int J Epidemiol; 1999 Apr; 28(2):341-6. PubMed ID: 10342701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
    Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
    East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological investigations on measles in unvaccinated and vaccinated children (author's transl)].
    Wiedermann G; Ambrosch F
    Wien Klin Wochenschr; 1976 Sep; 88(17):545-54. PubMed ID: 997537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles IgM response during reinfection of previously vaccinated children.
    Linnemann CC; Hegg ME; Rotte TC; Phair JP; Schiff GM
    J Pediatr; 1973 May; 82(5):798-801. PubMed ID: 4698953
    [No Abstract]   [Full Text] [Related]  

  • 20. Measles immunity and response to revaccination among secondary school children in Cumbria.
    Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
    Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.